Novel methyllycaconitine analogues selective for the α4β2 over α7 nicotinic acetylcholine receptors

Bioorg Med Chem. 2021 Dec 1:51:116516. doi: 10.1016/j.bmc.2021.116516. Epub 2021 Nov 10.

Abstract

Analogues of methyllycaconitine (MLA) based on a (3-ethyl-9-methylidene-3-azabicyclo[3.3.1]nonan-1-yl)methanol template have been designed and synthesised that incorporate the modified ester sidechains distinct from that present in the natural product. Electrophysiology experiments using Xenopus oocytes expressing nicotinic acetylcholine receptors (nAChRs) revealed selected analogues served as non-competitive inhibitors that showed selectivity for the α4β2 over α7 nAChR subtypes, and selectivity for the (α4)3(β2)2 over (α4)2(β2)3 stoichiometry. This study more clearly defines the biological effects of MLA analogues and identifies strategies for the development of MLA analogues as selective ligands for the α4β2 nAChR subtype.

Keywords: Alpha4beta2; Ligand-gated ion channel; Methyllycaconitine; Nicotinic acetylcholine receptor; Noncompetitive antagonist.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aconitine / analogs & derivatives
  • Aconitine / chemical synthesis
  • Aconitine / chemistry
  • Animals
  • Dose-Response Relationship, Drug
  • Molecular Structure
  • Oocytes / drug effects
  • Oocytes / metabolism
  • Receptors, Nicotinic / metabolism*
  • Structure-Activity Relationship
  • Xenopus laevis
  • alpha7 Nicotinic Acetylcholine Receptor / antagonists & inhibitors*
  • alpha7 Nicotinic Acetylcholine Receptor / metabolism

Substances

  • Receptors, Nicotinic
  • alpha7 Nicotinic Acetylcholine Receptor
  • nicotinic receptor alpha4beta2
  • methyllycaconitine
  • Aconitine